Come up with a name for your new list and we'll add to it:
Stella Therapeutics raised a round of funding on September 17, 2013. Investors include
Life Sciences Discovery Fund.
Stella Therapeutics, a privately held drug discovery company, is developing first-in-class small molecules that hold the promise of curing Glioblastoma Multiforme (GBM), the most common and deadliest …